无线射频芯片
Search documents
电科芯片:暂未涉及激光通讯芯片研发
Zheng Quan Ri Bao Wang· 2026-01-14 13:21
证券日报网讯 1月14日,电科芯片(600877)在互动平台回答投资者提问时表示,卫星通信领域是公司 重点业务方向之一,公司主要致力于无线射频芯片设计开发,暂未涉及激光通讯芯片研发。 ...
电科芯片:公司主要致力于无线射频芯片设计开发,暂未涉及激光通讯芯片研发
Ge Long Hui· 2026-01-14 09:22
Group 1 - The core focus of the company is on the satellite communication sector, which is identified as a key business direction [1] - The company is primarily engaged in the design and development of wireless radio frequency chips [1] - Currently, the company has not ventured into the research and development of laser communication chips [1]
电科芯片(600877.SH):公司主要致力于无线射频芯片设计开发,暂未涉及激光通讯芯片研发
Ge Long Hui· 2026-01-14 09:18
Group 1 - The core focus of the company is on the satellite communication sector, which is one of its key business directions [1] - The company is primarily engaged in the design and development of wireless radio frequency chips and has not yet ventured into the research and development of laser communication chips [1]
医药行业支付迎连续变革,中药将开启按病种付费试点,行业业绩增速也有望环比好转
Xuan Gu Bao· 2025-10-09 23:32
Group 1 - The National Healthcare Security Administration and the National Administration of Traditional Chinese Medicine have initiated a pilot program for disease-based payment for traditional Chinese medicine (TCM) in approximately 15 provinces or cities, aiming to reform payment methods over 2-3 years and gradually promote nationwide [1] - Longjiang Securities indicates that the DRG/DIP payment reform represents a significant change from project-based payments, providing new strategic opportunities for the innovative development of TCM [1] - CITIC Securities notes that while the collection of traditional Chinese medicine is being comprehensively promoted, the overall price reduction aligns with expectations, particularly for exclusive TCM prescription drugs, which have seen moderate price declines [1] Group 2 - Zheshang Securities highlights that the TCM industry possesses attributes similar to the banking sector, characterized by ample cash flow, high dividends, and low profit volatility, with expectations of improved revenue and net profit growth in the second quarter of 2025 compared to the first quarter [1] - The company Sichuang Medical is actively engaging in the DRG/DIP field, leveraging its medical information intelligent open platform to assist healthcare institutions in reforming payment methods [1]